Join the discussion, December 8-10, Washington DC: www.globalcvctforum.com/scientific-p...

Join us for ample discussion on how to bridge the gap from concept to clinic: www.globalcvctforum.com/scientific-p...

#CKLM #RNAtherapeutics #CardioInnovation #TranslationalMedicine #CVCT

Dr. John Spertus, MD, MPH, FACC has been selected by the 2025 CVCT Patient Advisory Board as the inaugural recipient for his pioneering innovation and continued excellence in Patient Engagement in Clinical Research. CONGRATULATIONS!

#CVCT #patienttrialists
www.globalcvctforum.com

Join us for what promises to be a fascinating insight into the leading-edge clinical science and the thinking driving progress in the field of hypertension. www.globalcvctforum.com/scientific-p...

Professor Bryan Williams OBE

With new therapeutic targets as aldosterone synthase, angiotensinogen, natriuretic peptides, as well as novel modes of therapeutic delivery such as RNA silencing and peptide modification to extend duration of action, the potential of these new treatments and their place in the hierarchy of therapy

Sessions will highlight practical IND strategies and frameworks for safety monitoring developed by leading teams. Experts will also discuss emerging models for ensuring safety, access, and reimbursement.
Join us, December 8-10, Washington DC! www.globalcvctforum.com/scientific-p...

Don’t miss your chance to share your work and be part of the global discussion shaping the future of cardiovascular clinical research!

For simultaneous full manuscript publication in JACC, please contact directly cvct-abstracts@overcome.fr for additional information.
For any additional questions, please contact us at cvct-abstracts@overcome.fr

2. Late-Breaking Clinical Trials (LBCTs)
Submissions for Late-Breaking Clinical Trials are also open until October 20, 2025.
👉Find the guidelines and the submission link here: www.globalcvctforum.com/late-breakin...

This session will include highly anticipated debates on the role and feasibility of placebo-controlled device trials as well as on the optimal approach to analysis and reporting of health status and quality of life endpoints.
Join us, Dec 8-10, Washington DC: www.globalcvctforum.com/scientific-p...

- All accepted abstracts will be published in the Journal of American College of Cardiology.
- Full manuscripts will be eligible for simultaneous publication with fast-track review by JACC.
Submission Deadline - October 15
Find out more here: www.globalcvctforum.com/late-breakin...

CVCT meeting attract global leaders representing all aspects of clinical trials including trialists, clinicians, sponsors, regulators, funders, payers, editors, and patients and advocacy groups. Your research results will find a broad expert audience.

and attempts to trigger a true myocardial regeneration by a mRNA-based activation of endogenous pathways involved in cardiomyocyte cycling and division.

Discover our scientific program and join us, December 8-10, 2025, Washingto, DC: www.globalcvctforum.com/scientific-p...

reassessment of delivery routes and dosing strategies taking into account the role of the immune landscape as a key driver of heart failure and aimed at streamlining the implementation of both cell-based and secretome-based strategies;

transplantation of cardiomyocytes differentiated from pluripotent stem cells to induce remuscularization of the chronically failing heart; switch towards the exclusive use of the cellular secretome shown to duplicate the cardio-protective effects of the parental cells;